Extracellular ATP Functions as a Metabolic Lineage Selection Signal That Stabilizes Tc9 Cells During Adoptive T Cell Therapy
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27073169 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jie Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Immunotherapy, Adoptive, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China https://ror.org/01h0zpd94.
Abstract (Originalsprache)
Adoptive T cell therapy (ACT) remains limited in solid tumors by poor T cell persistence within the metabolically hostile tumor microenvironment (TME). Although IL-9-producing CD8+ T cells (Tc9) consistently demonstrate superior antitumor efficacy compared with conventional Tc1 cells, the selective pressures that shape their functional advantage remain unclear. Here, we show that effective ACT-mediated tumor control is accompanied by a marked increase in intratumoral extracellular ATP (eATP), representing a common metabolic consequence of tumor cell destruction. Despite comparable ATP accumulation following Tc1 or Tc9 treatment, these subsets exhibit strikingly distinct responses to ATP stress. Tc1 cells are highly susceptible to ATP-induced apoptosis, whereas Tc9 cells display intrinsic resistance, resulting in superior in vivo persistence. Mechanistically, Tc9 cells actively convert ATP signaling into enhanced mitochondrial fitness, characterized by increased oxidative phosphorylation and spare respiratory capacity. ATP exposure further drives Tc9 cells toward a tissue-resident memory (TRM) phenotype through activation of the TGF-β signaling axis. Transcriptomic and molecular analyses reveal that purinergic signaling pathways, including elevated expression of the ATP receptor P2RX7, are intrinsically enriched in Tc9 cells and are further amplified upon ATP stimulation. Collectively, our findings identify extracellular ATP as a metabolic lineage selection signal in ACT, demonstrating that ATP stress preferentially stabilizes metabolically resilient Tc9 cells by linking purinergic sensing to mitochondrial remodeling and TRM programming, thereby providing a conceptual basis for enhancing the persistence and efficacy of engineered T cell therapies in solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
- Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China.
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of China https://ror.org/01h0zpd94
Zitieren
APA
Ren, J., Gong, Z., Zhong, Y., Xiao, R., Urooj, K., Gao, Y., Bi, E., & Wang, H. (2026). Extracellular ATP Functions as a Metabolic Lineage Selection Signal That Stabilizes Tc9 Cells During Adoptive T Cell Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073169
Vancouver
Ren J, Gong Z, Zhong Y, Xiao R, Urooj K, Gao Y, et al. Extracellular ATP Functions as a Metabolic Lineage Selection Signal That Stabilizes Tc9 Cells During Adoptive T Cell Therapy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073169
BibTeX
@article{Ren2026,
author = {Ren, Jie and Gong, Zhengrong and Zhong, Yutong and Xiao, Ruipei and Urooj, Khadija and Gao, Yuan and Bi, Enguang and Wang, Handuo},
title = {Extracellular ATP Functions as a Metabolic Lineage Selection Signal That Stabilizes Tc9 Cells During Adoptive T Cell Therapy},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27073169}
}
EUVIMED